Individual Article: Brodalumab Is an Efficacious, Safe, and Cost-Effective IL-17 Receptor Blocker for the Treatment of Moderate-to-Severe Plaque Psoriasis: 2023 Update

A Randomized Control Trial Comparing the Efficacy of Platelet-Rich Plasma and 5% Topical Minoxidil for the Treatment of Androgenetic Alopecia

Clinical Trial of Alpha and Beta Defensin Skin Care Regimen for Improvement of Periocular Wrinkles

Tildrakizumab in Combination With Topical Halcinonide 0.1% Ointment for Treating Moderate to Severe Plaque Psoriasis

Off-Label Use of Baricitinib in Dermatology

Real-World Effectiveness and Safety of Tildrakizumab in Patients With Moderate-to-Severe Psoriasis: Week 28 Interim Analysis of a Phase 4 Study

Ceramide-Containing Adjunctive Skin Care for Skin Barrier Restoration During Acne Vulgaris Treatment

Assessment and Evaluation of Online Content Available on Micrographic Surgery and Dermatologic Oncology Fellowship Websites

Optimizing Melasma Management With Topical Tranexamic Acid: An Expert Consensus

Brodalumab: 4-Year US Pharmacovigilance Report

Reversal of Stress-Associated Alopecia

Successful Management of Erythema Dyschromicum Perstans Following Topical Ruxolitinib Therapy